Publications searcher The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points. Fulltext search Alphabetic A-Z Alphabetic Z-A Advancing in shared decision making: asymptomatic carotid stenosis PMID: NOPMID0069 Journal: ANGIOLOGY Year: 2019 Reference: Advancing in shared decision making: asymptomatic carotid stenosis. Angiología. 2019;71(5):190-3. doi: 10.20960/angiologia.00052 Impact factor: 2.376 Publication type: Paper in national publication Authors: Morata Barrado, Pilar Caridad, Al-Raies Bolanos, Bader, Blanco Canibano, Estrella, Lopez Espada, Cristina, Barreiro Veiguela, Javier, Bellmunt Montoya, Sergi, Gil Sales, Jose, Florit Lopez, Salvador et al. DOI: 10.20960/angiologia.00052 Advancing in shared decision making: asymptomatic carotid stenosis PMID: NOPMID0069 Journal: ANGIOLOGY Year: 2019 Reference: Advancing in shared decision making: asymptomatic carotid stenosis. Angiología. 2019;71(5):190-3. doi: 10.20960/angiologia.00052 Impact factor: Publication type: Paper in national publication Authors: Al-Raies Bolanos, Bader; Barreiro Veiguela, Javier; Bellmunt Montoya, Sergi; Blanco Canibano, Estrella; Florit Lopez, Salvador; Gil Sales, Jose; Lopez Espada, Cristina; Morata Barrado, Pilar Caridad et al. DOI: 10.20960/angiologia.00052 Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis. PMID: 30624662 Journal: ANNALS OF ONCOLOGY Year: 2019 Reference: Ann Oncol. 2019 Jul 1;30(7):1179. doi: 10.1093/annonc/mdy535. Impact factor: 14.196 Publication type: Letter or abstract Authors: Cortes, J, Calvo, V, Ramirez-Merino, N, O'Shaughnessy, J, Brufsky, A, Robert, N, Vidal, M, Munoz, E, Perez, J, Dawood, S et al. DOI: 10.1093/annonc/mdy535 Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis. PMID: 30624662 Journal: ANNALS OF ONCOLOGY Year: 2019 Reference: Ann Oncol. 2019 Jul 1;30(7):1179. doi: 10.1093/annonc/mdy535. Impact factor: Publication type: Letter or abstract Authors: Baselga, J; Bellet, M; Brufsky, A; Calvo, V; Cortes, J; Dawood, S; Di Cosimo, S; Gonzalez-Martin, A; Llombart, A; Miles, D et al. DOI: 10.1093/annonc/mdy535 Afatinib in non-small cell lung cancer with HER2 mutations: results of the prospective, open-label phase II NICHE trial of European Thoracic Oncology Platform (ETOP). PMID: 30825613 Journal: Journal of Thoracic Oncology Year: 2019 Reference: J Thorac Oncol. 2019 Jun;14(6):1086-1094. doi: 10.1016/j.jtho.2019.02.017. Epub 2019 Feb 27. Impact factor: 12.46 Publication type: Paper in international publication Authors: Rabaglio, Manuela, Dziadziuszko, Rafal, Smit, Egbert F, Dafni, Urania, Wolf, Juergen, Wasag, Bartosz, Biernat, Wojciech, Finn, Stephen P, Kammler, Roswitha, Tsourti, Zoi et al. DOI: 10.1016/j.jtho.2019.02.017 Afatinib in non-small cell lung cancer with HER2 mutations: results of the prospective, open-label phase II NICHE trial of European Thoracic Oncology Platform (ETOP). PMID: 30825613 Journal: Journal of Thoracic Oncology Year: 2019 Reference: J Thorac Oncol. 2019 Jun;14(6):1086-1094. doi: 10.1016/j.jtho.2019.02.017. Epub 2019 Feb 27. Impact factor: Publication type: Paper in international publication Authors: Biernat, Wojciech; Dafni, Urania; Dziadziuszko, Rafal; Felip, Enriqueta; Finn, Stephen P; Kammler, Roswitha; Peters, Solange; Rabaglio, Manuela; Roschitzki-Voser, Heidi; Ruepp, Barbara et al. DOI: 10.1016/j.jtho.2019.02.017 Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial. PMID: 31194247 Journal: JAMA Oncology Year: 2019 Reference: JAMA Oncol. 2019 Jun 13. pii: 2735890. doi: 10.1001/jamaoncol.2019.1146. Impact factor: 22.416 Publication type: Paper in international publication Authors: Harrington, Kevin, de Souza Viana, Luciano, Romanov, Ilya, Vermorken, Jan, Bourhis, Jean, Tahara, Makoto, Martins Segalla, Jose Getulio, Psyrri, Amanda, Vasilevskaya, Irina, Nangia, Chaitali Singh et al. DOI: 10.1001/jamaoncol.2019.1146 Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial. PMID: 31194247 Journal: JAMA Oncology Year: 2019 Reference: JAMA Oncol. 2019 Jun 13. pii: 2735890. doi: 10.1001/jamaoncol.2019.1146. Impact factor: Publication type: Paper in international publication Authors: Asarawala, Nirav; Bourhis, Jean; Burtness, Barbara; Chaves-Conde, Manuel; Cohen, Ezra E W; de Souza Viana, Luciano; Del Campo, Josep Maria; Dinis, Jose; Ehrnrooth, Eva; Even, Caroline et al. DOI: 10.1001/jamaoncol.2019.1146 Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol. PMID: 30808583 Journal: Clinical Lung Cancer Year: 2019 Reference: Clin Lung Cancer. 2019 May;20(3):e407-e412. doi: 10.1016/j.cllc.2018.12.022. Epub 2019 Jan 4. Impact factor: 4.117 Publication type: Paper in international publication Authors: Levy, Benjamin, Paz-Ares, Luis, Bennouna, Jaafar, Felip, Enriqueta, Abreu, Delvys Rodriguez, Isla, Dolores, Barlesi, Fabrice, Molinier, Olivier, Madelaine, Jeannick, Audigier-Valette, Clarisse et al. DOI: 10.1016/j.cllc.2018.12.022 Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol. PMID: 30808583 Journal: Clinical Lung Cancer Year: 2019 Reference: Clin Lung Cancer. 2019 May;20(3):e407-e412. doi: 10.1016/j.cllc.2018.12.022. Epub 2019 Jan 4. Impact factor: Publication type: Paper in international publication Authors: Abreu, Delvys Rodriguez; Audigier-Valette, Clarisse; Badin, Firas Benyamine; Barlesi, Fabrice; Bennouna, Jaafar; Chisamore, Michael J; Erman, Mustafa; Felip, Enriqueta; Isla, Dolores; Kim, Hye Ryun et al. DOI: 10.1016/j.cllc.2018.12.022 Age-related metabolic changes limit efficacy of deoxynucleoside-based therapy in thymidine kinase 2-deficient mice. PMID: 31351931 Journal: EBioMedicine Year: 2019 Reference: EBioMedicine. 2019 Aug;46:342-355. doi: 10.1016/j.ebiom.2019.07.042. Epub 2019 Jul 24. Impact factor: 6.68 Publication type: Paper in international publication Authors: Molina-Granada, David, Vila-Julia, Ferran, Jimenez-Heis, Daniel, Zhou, Xiaoshan, Torres-Torronteras, Javier, Karlsson, Anna, Marti, Ramon, Camara, Yolanda, Blazquez-Bermejo, Cora et al. DOI: 10.1016/j.ebiom.2019.07.042 Age-related metabolic changes limit efficacy of deoxynucleoside-based therapy in thymidine kinase 2-deficient mice. PMID: 31351931 Journal: EBioMedicine Year: 2019 Reference: EBioMedicine. 2019 Aug;46:342-355. doi: 10.1016/j.ebiom.2019.07.042. Epub 2019 Jul 24. Impact factor: Publication type: Paper in international publication Authors: Blazquez-Bermejo, Cora; Camara, Yolanda; Jimenez-Heis, Daniel; Karlsson, Anna; Marti, Ramon; Molina-Granada, David; Torres-Torronteras, Javier; Vila-Julia, Ferran; Zhou, Xiaoshan et al. DOI: 10.1016/j.ebiom.2019.07.042 Agnostic-Histology Approval of new drugs in Oncology: are we already there? PMID: 30670489 Journal: CLINICAL CANCER RESEARCH Year: 2019 Reference: Clin Cancer Res. 2019 Jun 1;25(11):3210-3219. doi: 10.1158/1078-0432.CCR-18-3694. Epub 2019 Jan 22. Impact factor: 8.911 Publication type: Paper in international publication Authors: Hierro, Cinta, Matos, Ignacio, Martin-Liberal, Juan, Ochoa de Olza, Maria, Garralda, Elena et al. DOI: 10.1158/1078-0432.CCR-18-3694 Agnostic-Histology Approval of new drugs in Oncology: are we already there? PMID: 30670489 Journal: CLINICAL CANCER RESEARCH Year: 2019 Reference: Clin Cancer Res. 2019 Jun 1;25(11):3210-3219. doi: 10.1158/1078-0432.CCR-18-3694. Epub 2019 Jan 22. Impact factor: Publication type: Paper in international publication Authors: Garralda, Elena; Hierro, Cinta; Martin-Liberal, Juan; Matos, Ignacio; Ochoa de Olza, Maria et al. DOI: 10.1158/1078-0432.CCR-18-3694 Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases. PMID: 31639024 Journal: Orphanet Journal of Rare Diseases Year: 2019 Reference: Orphanet J Rare Dis. 2019 Oct 21;14(1):230. doi: 10.1186/s13023-019-1202-6. Impact factor: 3.687 Publication type: Paper in international publication Authors: Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Pardo-Mateos, Almudena, Malfettone, Andrea, Perez-Garcia, Jose, Llombart-Cussac, Antonio, Cortes, Javier, Molto-Abad, Marc, Munoz-Delgado, Cecilia, Perez-Quintana, Marta et al. DOI: 10.1186/s13023-019-1202-6 Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases. PMID: 31639024 Journal: Orphanet Journal of Rare Diseases Year: 2019 Reference: Orphanet J Rare Dis. 2019 Oct 21;14(1):230. doi: 10.1186/s13023-019-1202-6. Impact factor: Publication type: Paper in international publication Authors: Cortes, Javier; Llombart-Cussac, Antonio; Malfettone, Andrea; Miguel-Huguet, Bernat; Molto-Abad, Marc; Munoz-Delgado, Cecilia; Pardo-Mateos, Almudena; Perez-Garcia, Jose; Perez-Lopez, Jordi; Perez-Quintana, Marta et al. DOI: 10.1186/s13023-019-1202-6 Airway Alterations and Diffuse Alveolar Damage in Acute Respiratory Distress Syndrome: Is There Any Association? PMID: 29861071 Journal: ARCHIVOS DE BRONCONEUMOLOGIA Year: 2019 Reference: Arch Bronconeumol. 2019 Jan;55(1):3-4. doi: 10.1016/j.arbres.2018.04.003. Epub 2018 May 31. Impact factor: 4.214 Publication type: Paper in national publication Authors: Griffiths, Mark J D, Soriano-Navarro, Tania, Garcia-de-Acilu, Marina, Roca, Oriol et al. DOI: 10.1016/j.arbres.2018.04.003 Airway Alterations and Diffuse Alveolar Damage in Acute Respiratory Distress Syndrome: Is There Any Association? PMID: 29861071 Journal: ARCHIVOS DE BRONCONEUMOLOGIA Year: 2019 Reference: Arch Bronconeumol. 2019 Jan;55(1):3-4. doi: 10.1016/j.arbres.2018.04.003. Epub 2018 May 31. Impact factor: Publication type: Paper in national publication Authors: Garcia-de-Acilu, Marina; Griffiths, Mark J D; Roca, Oriol; Soriano-Navarro, Tania et al. DOI: 10.1016/j.arbres.2018.04.003 Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). PMID: 31053546 Journal: Annals of Hepatology Year: 2019 Reference: Ann Hepatol. 2019 May - Jun;18(3):518-535. doi: 10.1016/j.aohep.2019.04.005. Epub 2019 Apr 18. Impact factor: 1.895 Publication type: Paper in international publication Authors: Abraldes, Juan G, Arab, Juan P, Roblero, Juan P, Altamirano, Jose, Bessone, Fernando, Chaves Araujo, Roberta, Higuera-De la Tijera, Fatima, Restrepo, Juan Carlos, Torre, Aldo, Urzua, Alvaro et al. DOI: 10.1016/j.aohep.2019.04.005 Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). PMID: 31053546 Journal: Annals of Hepatology Year: 2019 Reference: Ann Hepatol. 2019 May - Jun;18(3):518-535. doi: 10.1016/j.aohep.2019.04.005. Epub 2019 Apr 18. Impact factor: Publication type: Paper in international publication Authors: Abraldes, Juan G; Altamirano, Jose; Arab, Juan P; Bataller, Ramon; Bessone, Fernando; Chaves Araujo, Roberta; Contreras, Fernando; Cortez-Pinto, Helena; Higuera-De la Tijera, Fatima; Lucey, Michael R et al. DOI: 10.1016/j.aohep.2019.04.005 Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH. PMID: 31771785 Journal: Gastroenterologia y Hepatologia Year: 2019 Reference: Gastroenterol Hepatol. 2019 Dec;42(10):657-676. doi: 10.1016/j.gastrohep.2019.09.006. Epub 2019 Nov 23. Impact factor: 1.126 Publication type: Paper in national publication Authors: Bataller, Ramon, Cabezas, Joaquin, Aller, Rocio, Ventura-Cots, Meritxell, Abad, Javier, Albillos, Agustin, Altamirano, Jose, Arias-Loste, Maria Teresa, Banares, Rafael, Caballeria, Juan et al. DOI: 10.1016/j.gastrohep.2019.09.006 Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH. PMID: 31771785 Journal: Gastroenterologia y Hepatologia Year: 2019 Reference: Gastroenterol Hepatol. 2019 Dec;42(10):657-676. doi: 10.1016/j.gastrohep.2019.09.006. Epub 2019 Nov 23. Impact factor: Publication type: Paper in national publication Authors: Abad, Javier; Albillos, Agustin; Aller, Rocio; Altamirano, Jose; Arias-Loste, Maria Teresa; Banares, Rafael; Bataller, Ramon; Caballeria, Juan; Caballeria, Llorenc; Cabezas, Joaquin et al. DOI: 10.1016/j.gastrohep.2019.09.006 ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer. PMID: 30892989 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2019 Reference: J Clin Oncol. 2019 Jun 1;37(16):1370-1379. doi: 10.1200/JCO.18.02236. Epub 2019 Mar 20. Impact factor: 28.245 Publication type: Paper in international publication Authors: Shaw, Alice T, Solomon, Benjamin J, Besse, Benjamin, Bauer, Todd M, Lin, Chia-Chi, Soo, Ross A, Riely, Gregory J, Ou, Sai-Hong Ignatius, Clancy, Jill S, Li, Sherry et al. DOI: 10.1200/JCO.18.02236 ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer. PMID: 30892989 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2019 Reference: J Clin Oncol. 2019 Jun 1;37(16):1370-1379. doi: 10.1200/JCO.18.02236. Epub 2019 Mar 20. Impact factor: Publication type: Paper in international publication Authors: Abbattista, Antonello; Bauer, Todd M; Besse, Benjamin; Camidge, D Ross; Chiari, Rita; Clancy, Jill S; Felip, Enriqueta; Gadgeel, Shirish M; Kao, Steven; Li, Sherry et al. DOI: 10.1200/JCO.18.02236 Pagination First page « First Previous page ‹ Previous … Page 661 Page 662 Page 663 Page 664 Current page 665 Page 666 Page 667 Page 668 Page 669 … Next page Next › Last page Last »
